메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Purpose The aim of this study is to identify the prognostic factors of distant metastasis (DM) afterinduction chemotherapy (IC) followed by concurrent chemoradiotherapy (CRT) for locoregionallyadvanced head and neck cancer (HNC). Materials and MethodsA total of 321 patients with HNC who underwent IC followed by CRT treated between January2005 and December 2010 were analyzed retrospectively. IC consisted of three courses ofdocetaxel (70 mg/m2) and cisplatin (75 mg/m2) every three weeks, followed by radiotherapyof 66-70 Gy/2 Gy per fraction/5 fractions per week concurrent with weekly cisplatin (40mg/m2). Tumor/nodal stage, primary site, tumor differentiation, lower neck node involvement(level IV, VB, and supraclavicular regions), number of concurrent chemotherapy cycles,overall duration of radiotherapy, and response to IC were assessed as potential prognosticfactors influencing DM and survival outcome. ResultsThe five-year loco-regional recurrence and DM rates were 23.6% and 18.2%. N stage, overallduration of radiotherapy, lower neck node involvement, and response to IC were significantfactors for DM. With a median follow-up period of 52 months (range, 4 to 83 months), the5-year progression-free, DM-free, and overall survival rates were 41.2%, 50.7%, and 55.1%,respectively. Lower neck node involvement (p=0.008) and poor response to IC (p < 0.001)showed an association with significantly inferior DM-free survival. ConclusionEven with the addition of IC, the DM rate and survival outcome were poor when metastaticlower neck lymph nodes were present or when patients failed to respond after receiving IC.

목차

등록된 정보가 없습니다.

참고문헌 (22)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0